Pillstats
Rx only · Capsule · Oral

Rivastigmine Tartrate

Rivastigmine Tartrate

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US42 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers11 labelers
Packages130
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 42 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.053$0.105$0.158$0.210Dec 2025Mar 2026Jun 2026
$0.172
Latest avg · Jun 17, 2026
-6%
Since Dec 17, 2025
11
Active US suppliers
43%
Top-2 supplier share*

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown40SUPPLYING
Dr.Reddy's laboratories Limitedunknown16SUPPLYING
Aurobindo Pharma Limitedunknown16SUPPLYING
Macleods Pharmaceuticals Limitedunknown16SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown12SUPPLYING
Modavar Pharmaceuticals LLCunknown8SUPPLYING
Cadila Pharmaceuticals Limitedunknown8SUPPLYING
Nivagen Pharmaceuticals, Inc.unknown8SUPPLYING
Chartwell RX, LLCunknown4SUPPLYING
American Health Packagingunknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.